Ketamine One Appoints Joe Ramelli as Its New Chief Financial Officer

VANCOUVER, British Columbia, Dec. 14, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that Joe Ramelli has been appointed as Ketamine One’s new Chief Financial Officer (“CFO”) effective December 14, 2021, subject to the final acceptance of the NEO Exchange. Mr. Ramelli holds a Bachelor of Arts (with honours) in Business Economics from the University of California, Santa Barbara and has also attended the Director Education and Certification Program at the UCLA’s Anderson School of Management. Read More